Evaluation of the Safety and Immunogenicity of the RTS,S/AS01 E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

Autor: Agnandji, Selidji T., Asante, Kwaku Poku, Lyimo, John, Vekemans, Johan, Soulanoudjingar, Solange S., Owusu, Ruth, Shomari, Mwanajaa, Leach, Amanda, Fernandes, Jose, Dosoo, David, Chikawe, Maria, Issifou, Saadou, Osei-Kwakye, Kingsley, Lievens, Marc, Paricek, Maria, Apanga, Stephen, Mwangoka, Grace, Okissi, Blaise, Kwara, Evans, Minja, Rose, Lange, Jorn, Boahen, Owusu, Kayan, Kingsley, Adjei, George, Chandramohan, Daniel, Jongert, Erik, Demoitié, Marie-Ange, Dubois, Marie-Claude, Carter, Terrel, Vansadia, Preeti, Villafana, Tonya, Sillman, Marla, Savarese, Barbara, Lapierre, Didier, Ballou, William Ripley, Greenwood, Brian, Tanner, Marcel, Cohen, Joe, Kremsner, Peter G., Lell, Bertrand, Owusu-Agyei, Seth, Abdulla, Salim

Publikováno v: The Journal of Infectious Diseases, 2010 Oct 01. 202(7), 1076-1087.

Externí odkaz: https://www.jstor.org/stable/20780228

Haematological and Biochemical Reference Values for Healthy Adults in the Middle Belt of Ghana.

Autor: Dosoo, David K.¹, Kayan, Kingsley¹, Adu-Gyasi, Dennis¹, Kwara, Evans¹, Ocran, Josephine², Kwakye, Kingsley Osei-¹, Mahama, Emmanuel¹, Amenga-Etego, Stephen¹, Bilson, Philip¹, Asante, Kwaku P.¹, Koram, Kwadwo A.², Owusu-Agyei, Seth¹ seth.owusu-agyei@kintampo-hrc.org

Publikováno v: PLoS ONE. Apr2012, Vol. 7 Issue 4, p1-9. 9p.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

Autor: RTS,S Clinical Trials Partnership, Agnandji, Selidji Todagbe, Lell, Bertrand, Soulanoudjingar, Solange Solmeheim, Fernandes, José Francisco, Abossolo, Béatrice Peggy, Conzelmann, Cornelia, Methogo, Barbara Gaelle Nfono Ondo, Doucka, Yannick, Flamen, Arnaud, Mordmüller, Benjamin, Issifou, Saadou, Kremsner, Peter Gottfried, Sacarlal, Jahit, Aide, Pedro, Lanaspa, Miguel, Aponte, John J, Nhamuave, Arlindo, Quelhas, Diana, Bassat, Quique, Mandjate, Sofia, Macete, Eusébio, Alonso, Pedro, Abdulla, Salim, Salim, Nahya, Juma, Omar, Shomari, Mwanajaa, Shubis, Kafuruki, Machera, Francisca, Hamad, Ali Said, Minja, Rose, Mtoro, Ali, Sykes, Alma, Ahmed, Saumu, Urassa, Alwisa Martin, Ali, Ali Mohammed, Mwangoka, Grace, Tanner, Marcel, Tinto, Halidou, D'Alessandro, Umberto, Sorgho, Hermann, Valea, Innocent, Tahita, Marc Christian, Kaboré, William, Ouédraogo, Sayouba, Sandrine, Yara, Guiguemdé, Robert Tinga, Ouédraogo, Jean Bosco, Hamel, Mary J, Kariuki, Simon, Odero, Chris, Oneko, Martina, Otieno, Kephas, Awino, Norbert, Omoto, Jackton, Williamson, John, Muturi-Kioi, Vincent, Laserson, Kayla F, Slutsker, Laurence, Otieno, Walter, Otieno, Lucas, Nekoye, Otsyula, Gondi, Stacey, Otieno, Allan, Ogutu, Bernhards, Wasuna, Ruth, Owira, Victorine, Jones, David, Onyango, Agnes Akoth, Njuguna, Patricia, Chilengi, Roma, Akoo, Pauline, Kerubo, Christine, Gitaka, Jesse, Maingi, Charity, Lang, Trudie, Olotu, Ally, Tsofa, Benjamin, Bejon, Philip, Peshu, Norbert, Marsh, Kevin, Owusu-Agyei, Seth, Asante, Kwaku Poku, Osei-Kwakye, Kingsley, Boahen, Owusu, Ayamba, Samuel, Kayan, Kingsley, Owusu-Ofori, Ruth, Dosoo, David, Asante, Isaac, Adjei, George, Chandramohan, Daniel, Greenwood, Brian, Lusingu, John, Gesase, Samwel, Malabeja, Anangisye, Abdul, Omari, Kilavo, Hassan, Mahende, Coline, Liheluka, Edwin, Lemnge, Martha, Theander, Thor, Drakeley, Chris, Ansong, Daniel, Agbenyega, Tsiri, Adjei, Samuel, Boateng, Harry Owusu, Rettig, Theresa, Bawa, John, Sylverken, Justice, Sambian, David, Agyekum, Alex, Owusu, Larko, Martinson, Francis, Hoffman, Irving, Mvalo, Tisungane, Kamthunzi, Portia, Nkomo, Ruthendo, Msika, Albans, Jumbe, Allan, Chome, Nelecy, Nyakuipa, Dalitso, Chintedza, Joseph, Ballou, W Ripley, Bruls, Myriam, Cohen, Joe, Guerra, Yolanda, Jongert, Erik, Lapierre, Didier, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Vekemans, Johan, Carter, Terrell, Leboulleux, Didier, Loucq, Christian, Radford, Afiya, Savarese, Barbara, Schellenberg, David, Sillman, Marla, Vansadia, Preeti

BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. METHODS: From March 2009 through January 2011, we enrolled 15,460 children in two

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3007e93080adaf923eb3795c29a66392
https://researchonline.lshtm.ac.uk/id/eprint/39130/1/nejmoa1102287.pdf

Non-malaria fevers in a high malaria endemic area of Ghana.

Autor: Asante, Kwaku Poku, Owusu-Agyei, Seth, Cairns, Matthew, Boamah, Ellen, Manu, Grace, Twumasi, Mieks, Gyasi, Richard, Adjei, George, Kayan, Kingsley, Mahama, Emmanuel, Kwame Dosoo, David, Koram, Kwadwo, Greenwood, Brian, Chandramohan, Daniel, Dosoo, David Kwame

Publikováno v: BMC Infectious Diseases; 7/11/2016, Vol. 16, p1-10, 10p, 1 Diagram, 5 Charts, 1 Graph

T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children.

Autor: Ansong, Daniel, Asante, Kwaku P., Vekemans, Johan, Owusu, Sandra K., Owusu, Ruth, Brobby, Naana A. W., Dosoo, David, Osei-Akoto, Alex, Osei-Kwakye, Kingsley, Asafo-Adjei, Emmanuel, O.^Boahen, Kwadwo, Sylverken, Justice, Adjei, George, Sambian, David, Apanga, Stephen, Kayan, Kingsley, Janssens, Michel H., Lievens, Marc J. J., Olivier, Aurelie C., Jongert, Erik

Publikováno v: PLoS ONE; 2011, Vol. 6 Issue 4, p1-9, 9p